Pretrial Rulings Regarding Litigation Funding

By John Freund |

It’s been said that non-pharma-related patent litigation tends to focus on a few big companies. Most are consumer-facing brands with their own retail outlets, though certainly not all. Those who make a career out of being a non-practicing entity (NPE) know who they are and how to target them.

Please log in to view membership only content
Log In Register

Premium

View All

Legal Finance SE Announces Plans to Fund Hundreds of Lawsuits Against Illegal Online Casinos

By Harry Moran |

It’s been said that non-pharma-related patent litigation tends to focus on a few big companies. Most are consumer-facing brands with their own retail outlets, though certainly not all. Those who make a career out of being a non-practicing entity (NPE) know who they are and how to target them.

Please log in to view membership only content
Log In Register

Federal Judges Argue Against Public Disclosure of Litigation Funding

By Harry Moran |

It’s been said that non-pharma-related patent litigation tends to focus on a few big companies. Most are consumer-facing brands with their own retail outlets, though certainly not all. Those who make a career out of being a non-practicing entity (NPE) know who they are and how to target them.

Please log in to view membership only content
Log In Register

Factor Risk Management Launches M&A and Transactional Risks Department

By Harry Moran |

It’s been said that non-pharma-related patent litigation tends to focus on a few big companies. Most are consumer-facing brands with their own retail outlets, though certainly not all. Those who make a career out of being a non-practicing entity (NPE) know who they are and how to target them.

Please log in to view membership only content
Log In Register